Emenda Therapeutics Ltd
- Company number
- 11695185
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 26 Nov 2018
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DONALDSON, Lucy Frances, Professor | Director | 26 Nov 2018 | |
| MORRIS, Jonathan, Professor | Director | 26 Nov 2018 | 30 Aug 2026 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Emenda Therapeutics Australia Pty Ltd | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent |
1 Mar 2023 | |
| Professor Jonathan Morris | Significant Influence Or Control | 24 Nov 2019 | 1 Mar 2023 |
| Professor Steven James Harper | Significant Influence Or Control | 24 Nov 2019 | 1 Mar 2023 |
| Professor Lucy Frances Donaldson | Significant Influence Or Control | 24 Nov 2019 | 1 Mar 2023 |
| Professor David Owen Bates | Significant Influence Or Control | 24 Nov 2019 | 16 Jul 2021 |
Accounts
| Year ended | Cash | Employees |
|---|---|---|
| 31 May 2025 | £7,646 | 0 |
| 31 May 2024 | £7,931 | 0 |
| 31 May 2023 | £8,967 | 0 |
| 31 May 2022 | £29,699 | 6 |
| 31 May 2021 | £38,713 | 5 |
| 30 Nov 2019 | £141,148 | 5 |
Connections
Registered address
261 companies are registered at this address - likely a registration agent.